Report

Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

Science  05 Jul 2002:
Vol. 297, Issue 5578, pp. 102-104
DOI: 10.1126/science.1071489

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Pharmacological inactivation of oncogenes is being investigated as a possible therapeutic strategy for cancer. One potential drawback is that cessation of such therapy may allow reactivation of the oncogene and tumor regrowth. We used a conditional transgenic mouse model forMYC-induced tumorigenesis to demonstrate that brief inactivation of MYC results in the sustained regression of tumors and the differentiation of osteogenic sarcoma cells into mature osteocytes. Subsequent reactivation of MYC did not restore the cells' malignant properties but instead induced apoptosis. Thus, brief MYC inactivation appears to cause epigenetic changes in tumor cells that render them insensitive to MYC-induced tumorigenesis. These results raise the possibility that transient inactivation of MYC may be an effective therapy for certain cancers.

  • * These authors contributed equally to this work.

  • To whom correspondence should be addressed. E-mail: dfelsher{at}leland.stanford.edu

View Full Text

Cited By...